Erik Abner

https://www.etis.ee/CV/Erik_Abner/eng

Date of birth

25.06.1986

E-mail

Please add here only on e-mail address. At this address you will receive ETIS messages (incl financing decisions).

erik.abner@ut.ee

ORCID

0000-0002-6529-3161

Additional information in English

Languages:

Estonian - native
English - fluent
German - fluent
Spanish - good

Career

Institutions and positions

01.01.2021–...

University of Tartu, Faculty of Science and Technology, Institute of Genomics, Research Fellow of Functional Genomics (1,00)

01.12.2019–31.12.2020

University of Tartu, Institute of Genomics, Research Fellow of Functional Genomics (1,00)

18.03.2019–30.11.2019

University of Tartu, Institute of Genomics, Senior Specialist (1,00)

30.01.2017–12.06.2017

Francis Crick Institute, Postdoctoral Training Fellow (1,00)

01.02.2012–10.01.2017

Molecular Biology Institute of Barcelona, PhD Student (1,00)

Education

2012–2016

Pompeu Fabra University, Biomedicine ; PhD

2010–2012

Maastricht University, Clinical Molecular Sciences ; MSc

2005–2010

Tallinn University of Technology, Gene Technology ; BSc

Qualifications

Academic degrees

Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.

Honours & awards

2020, Erik Abner, Marie Skłodowska-Curie Individual Fellowship

2016, Erik Abner, Cum Laude, Biomedicine, Pompeu Fabra University (Barcelona), Spain

2016, Erik Abner, "International Doctor" mention in the Doctoral Diploma

Fields of research

ETIS CLASSIFICATION: 3. Health; 3.1. Biomedicine; CERCS CLASSIFICATION: B726 Clinical biology

ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.2. Microbiology; CERCS CLASSIFICATION: B230 Microbiology, bacteriology, virology, mycology

Additional information

Visiting student during PhD program;
Harvard Medical School;
Supervisor: Monty Montano;
January 2016 - May 2016

Publications

Category

Year

Publication

1.1.

2020

Perrot, Nicolas; Valerio, Vincenza; Moschetta, Donato; Boekholdt, S. Matthijs; Dina, Christian; Chen, Hao Yu; Abner, Erik; Martinsson, Andreas; Manikpurage, Hasanga D.; Rigade, Sidwell; Capoulade, Romain; Mass, Elvira; Clavel, Marie-Annick; Le Tourneau, Thierry; Messika-Zeitoun, David; Wareham, Nicholas J.; Engert, James C.; Polvani, Gianluca; Pibarot, Philippe; Esko, Tõnu ... Arsenault, Benoit J. (2020). Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis. Jacc: Basic To Translational Science, 5 (7), 649−661. DOI: 10.1016/j.jacbts.2020.05.004.

1.1.

2019

Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34. DOI: 10.1016/j.antiviral.2019.03.008.

1.1.

2019

Stoszko, Mateusz; Ne, Enrico; Abner, Erik; Mahmoudi, Tokameh (2019). A broad drug arsenal to attack a strenuous latent HIV reservoir. Current Opinion in Virology, 38, 37−53. DOI: 10.1016/j.coviro.2019.06.001.

1.1.

2018

Abner, Erik; Stoszko, Mateusz; Zeng, Lei; Chen, Heng-Chang; Izquierdo-Bouldstridge, Andrea; Konuma, Tsuyoshi; Zorita, Eduard; Fanunza, Elisa; Zhang, Qiang; Mahmoudi, Tokameh; Zhou, Ming-Ming; Filion, Guillaume J.; Jordan, Albert (2018). A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs. Journal of Virology, 92 (10), UNSP e02056-17. DOI: 10.1128/JVI.02056-17.

Last update

4.02.2021

Erik Abner

https://www.etis.ee/CV/Erik_Abner/est

Sünniaeg

25.06.1986

E-post

Please add here only on e-mail address. At this address you will receive ETIS messages (incl financing decisions).

erik.abner@ut.ee

ORCID

0000-0002-6529-3161

Additional information in Estonian

Keeled:
eesti keel - emakeel
inglise keel - väga hea
saksa keel - väga hea
hispaania keel - hea

Teenistuskäik

Töökohad ja ametid

01.01.2021–...

Tartu Ülikool, Loodus- ja täppisteaduste valdkond, genoomika instituut, funktsionaalse genoomika teadur (1,00)

01.12.2019–31.12.2020

Tartu Ülikool, Tartu Ülikooli genoomika instituut, funktsionaalse genoomika teadur (1,00)

18.03.2019–30.11.2019

Tartu Ülikool, Tartu Ülikooli genoomika instituut, peaspetsialist (1,00)

30.01.2017–12.06.2017

Francis Cricki Instituut, Järeldoktor (1,00)

01.02.2012–10.01.2017

Molecular Biology Institute of Barcelona, Doktorant (1,00)

Haridustee

2012–2016

Pompeu Fabra Ülikool, Biomedicine ; PhD

2010–2012

Maastrichti Ülikool, Clinical Molecular Sciences ; MSc

2005–2010

Tallinna Tehnikaülikool, Geenitehnoloogia ; BSc

Kvalifikatsioon

Teaduskraadid

Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.

Teaduspreemiad ja tunnustused

2020, Erik Abner, Marie Skłodowska-Curie individuaalgrant

2016, Erik Abner, Cum Laude, Biomeditsiin, Pompeu Fabra Ülikool (Barcelona), Hispaania

2016, Erik Abner, "International Doctor" äramärkimine doktorantuuri diplomis

Teadustöö põhisuunad

ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.1. Biomeditsiin; CERCS KLASSIFIKAATOR: B726 Kliiniline bioloogia

ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS KLASSIFIKAATOR: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia

Lisainfo

Külalisdoktorant;
Harvard Medical School;
Juhendaja: Monty Montano;
Jaanuar 2016 - Mai 2016

Publikatsioonid

Klass

Aasta

Publikatsioon

1.1.

2020

1.1.

2019

Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34. DOI: 10.1016/j.antiviral.2019.03.008.

1.1.

2019

1.1.

2018

Last update

4.02.2021

Found 3 results

Program	Number	Name	Project start	Project end	Principal investigator	Institution	Financing

1.2.5.	MP1GV17428; MP1GI17428 (2R01DK075787-11)	Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum	15.08.2017	31.07.2020	Tõnu Esko	University of Tartu, Estonian Genome Center ; University of Tartu, Institute of Genomics	155 127,53 EUR
1.1.5.3.4.1.3.2.; 1.2.3.6.3.1.	SP1GI20181T (MOBERA21)	Investigating DETerminants of atrial Electrical ConducTion underlying ARRHYTHMIAS (ERA-CVD)	01.04.2020	30.04.2022	Tõnu Esko	University of Tartu, Institute of Genomics	144 245,20 EUR
PRG	PRG1291	Sytematic phenome-wide search for genetic modulators in health and disease	01.01.2021	31.12.2025	Tõnu Esko	University of Tartu, Institute of Genomics	237 875,00 EUR

GUID	Short reference	Project number	Start date	End date
Finance program	Partner ID	at the project	Financier subproject number	Institution project number	Project SFOS number	Title	Title in English	Title in original language	Acronym	Annotation
Annotation in English	the priority development area	Project type	Type	Type of activity and percentage	Field and speciality	Principal investigator	Responsible executor (guid)	Related persons	Related people (guid)	Institution
Asutus (guid)	Institution on begin date	Agency 2	Financing institutions	Specification	Industrial property	URL	Files	Comment	Keywords	Public
Partners	Asutuse registrisse kande tegemise kuupäev	Vastutava täitja poolne allkirjastamise kuupäev	Asutuse esindaja	Finantseerija esindaja	Menetleja kontaktisik	name of the creator of the item	Created	Item Modifier last name	change time	funding
Financing	Self-financing	Self-financing in other currency	Cofinancing	Cofinancing in other currency	Project was suspended	Project total financing	Is the distribution of periods calculated by ETIS?	Finance

Eesti Teadusinfosüsteem

Erik Abner

Career

Qualifications

Publications

Erik Abner

Teenistuskäik

Kvalifikatsioon

Publikatsioonid

Search project

Eesti Teadusinfosüsteem

Erik Abner

Career

Qualifications

Publications

Erik Abner

Teenistuskäik

Kvalifikatsioon

Publikatsioonid

Search project

{{title}}

{{title}}

Search program